The Journal of the Pharmacy Society of Wisconsin
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2025
    • JPSW 2024
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Submit a Manuscript
  • Contact
    • Editorial Advisory Committee

Thrombolytics for Pulmonary Embolisms: A Narrative Review

by Sage L. Orlowski, 2025 PharmD Candidate, Soriene N. Ozcan, 2025 PharmD Candidate, Katherine M. Bush, 2024 PharmD Candidate

"Pulmonary embolism (PE) is a type of venous thromboembolism (VTE) where the pulmonary artery, or its smaller connecting arteries, are blocked, and can lead to significant morbidity and mortality. Thrombolytic therapy can be beneficial in treating pulmonary embolism. First generation thrombolytics include urokinase (Kinlytic®) and streptokinase (Streptase®); second generation thrombolytics include alteplase (Activase®) (tPA); and third generation thrombolytics are tenecteplese (TNKase®) and reteplase (Retavase®). The use of thrombolytics in patients with pulmonary embolisms is progressing rapidly and, in some cases, can be lifesaving, but there are several patient-specific factors and adverse effects that must be considered for each patient case, which may potentially lead to hesitancy when considering thrombolytic agents."


Keywords: Reteplase, Tissue Plasminogen Activator, Fibrinolytic Agents, Tenecteplase, Urokinase-type Plasminogen Activator, Streptokinase, Venous Thromboembolism, Pulmonary Embolism, Iatrogenic Disease, Morbidity​

Download PDF

2023 July/August Table of Contents 

The Journal of the Pharmacy Society of Wisconsin (ISSN 2837-8229)


Past Issues

2025
2024

2
023
2020
2021
​2022
2019
2018
2017

About PSW

www.pswi.org

Contact Us

[email protected]
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2025
    • JPSW 2024
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Submit a Manuscript
  • Contact
    • Editorial Advisory Committee